Literature DB >> 27856664

The gut-brain connection: triggering of brain autoimmune disease by commensal gut bacteria.

Hartmut Wekerle1.   

Abstract

In a transgenic model of spontaneous experimental autoimmune encephalomyelitis, autoimmune attack against the CNS requires the presence of an intact commensal gut flora. Extending this observation to human autoimmune disease, such as multiple sclerosis, we postulate that the pathogenic reaction requires the coincidence of at least three factors: a permissive genetic disposition, a pro-inflammatory intestinal microbial profile, and the accumulation of autoreactive T cells in the gut-associated lymphatic tissue. This concept may offer new approaches to diagnostic markers and non-invasive therapies.
© The Author 2016. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  T lymphocytes; autoimmunity; intestine; microbiota; multiple sclerosis; myelin; neuroimmunology

Mesh:

Year:  2016        PMID: 27856664     DOI: 10.1093/rheumatology/kew353

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  11 in total

1.  Autoimmune diabetes mellitus and the leaky gut.

Authors:  Anneli Peters; Hartmut Wekerle
Journal:  Proc Natl Acad Sci U S A       Date:  2019-07-09       Impact factor: 11.205

Review 2.  Diet, Gut Microbiota, and Vitamins D + A in Multiple Sclerosis.

Authors:  Paolo Riccio; Rocco Rossano
Journal:  Neurotherapeutics       Date:  2018-01       Impact factor: 7.620

3.  Variations in diet cause alterations in microbiota and metabolites that follow changes in disease severity in a multiple sclerosis model.

Authors:  J E Libbey; J M Sanchez; D J Doty; J T Sim; M F Cusick; J E Cox; K F Fischer; J L Round; R S Fujinami
Journal:  Benef Microbes       Date:  2018-01-30       Impact factor: 4.205

Review 4.  Emerging Approaches for Validating and Managing Multiple Sclerosis Relapse.

Authors:  Elizabeth A Mills; Ali Mirza; Yang Mao-Draayer
Journal:  Front Neurol       Date:  2017-03-29       Impact factor: 4.003

Review 5.  Why monkeys do not get multiple sclerosis (spontaneously): An evolutionary approach.

Authors:  Riley M Bove
Journal:  Evol Med Public Health       Date:  2018-01-23

6.  Neuroimmunology Research. A Report from the Cuban Network of Neuroimmunology.

Authors:  María de Los Angeles Robinson-Agramonte; Lourdes Lorigados Pedre; Orlando Ramón Serrano-Barrera
Journal:  Behav Sci (Basel)       Date:  2018-05-08

7.  Alterations of Gut Microbiota and the Brain-Immune-Intestine Axis in Patients With Relapsing-Remitting Multiple Sclerosis After Treatment With Oral Cladribine: Protocol for a Prospective Observational Study.

Authors:  Jeske van Pamelen; Lynn van Olst; Andries E Budding; Helga E de Vries; Leo H Visser
Journal:  JMIR Res Protoc       Date:  2020-07-29

Review 8.  Some Candidate Drugs for Pharmacotherapy of Alzheimer's Disease.

Authors:  Barbara Miziak; Barbara Błaszczyk; Stanisław J Czuczwar
Journal:  Pharmaceuticals (Basel)       Date:  2021-05-13

Review 9.  Microbiome and Autoimmune Uveitis.

Authors:  Reiko Horai; Rachel R Caspi
Journal:  Front Immunol       Date:  2019-02-19       Impact factor: 7.561

Review 10.  Gut microbiota and pro/prebiotics in Alzheimer's disease.

Authors:  Ryszard Pluta; Marzena Ułamek-Kozioł; Sławomir Januszewski; Stanisław J Czuczwar
Journal:  Aging (Albany NY)       Date:  2020-03-19       Impact factor: 5.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.